The American Diabetes Association has issued updated guidelines on prevention, assessment and treatment of diabetic retinopathy (DR) for providers and for people with diabetes. The detailed recommendations are featured in an article recently published online in Diabetes Care. The position statement includes information on advancements in DR assessment and treatment methods, as well as improvements in managing diabetes that have developed since its prior DR position statement in 2002. The statement outlines the stages of DR and highlights recommendations on optimal blood glycemic control and lowering blood pressure. It also cites studies that have shown the positive effects tight glycemic control can have on DR risks and progressions in patients with diabetes, and how those benefits can last for years. Screening recommendations are also included, with the Association suggesting that adults with type 1 diabetes have a comprehensive eye exam within five years of the onset of diabetes, and that people with type 2 diabetes have an exam at the time of diagnosis. Additionally, it is recommended that women with preexisting diabetes who are pregnant or planning to become pregnant should be educated on the risks of developing DR. Specific treatment and management recommendations are also outlined in the position statement. More information can be found at http://www.prnewswire.com/news-releases/american-diabetes-association-issues-diabetic-retinopathy-position-statement-300411071.html.